
    
      The primary objective of the present study is to explore the effects of azilsartan 20 mg,
      compared with telmisartan 40 mg, once daily orally for 12 weeks on insulin resistance in
      participants with essential hypertension complicated by type 2 diabetes mellitus.
    
  